Oklo Inc. OKLO is preparing to expand the capabilities of its Groves Isotope Test Reactor (Groves-1) after receiving clearance from the U.S. Department of Energy (DOE) to begin unrestricted operations. The approval marks an important milestone for the advanced nuclear technology company, allowing the facility to move beyond its initial reactor demonstration phase and focus on research, equipment testing and workforce training.
The reactor, which achieved first criticality in August 2026 under the DOE's Reactor Pilot Program (RPP), became the first facility to reach this milestone under the program on private land. Its successful development has also demonstrated Oklo's ability to take a nuclear project from initial construction to operational readiness in less than a year.
Groves-1 to Strengthen Oklo's Reactor Development Capabilities
With the final operational hold point cleared, Oklo plans to use Groves-1 as a platform to evaluate technologies and operating procedures that could support its future isotope reactors and Aurora fast fission powerhouses. The experience gained during the reactor's initial deployment is expected to help the company establish the technical systems, operational processes and workforce capabilities required for additional nuclear projects.
Oklo has already started incorporating practical operating experience into its development process. During a recent reactor startup, operators used eye-tracking glasses to monitor their visual attention and identify areas for improvement in the human-machine interface. The information gathered could help the company refine reactor controls and incorporate better design features into future facilities.
Groves-1 will also support personnel training and qualification for upcoming reactor deployments. In addition, Oklo intends to continue evaluating equipment performance, particularly the reliability and functioning of control rod drive mechanisms.
Testing Activities Could Support Broader Nuclear Applications
Beyond workforce development and equipment evaluations, Groves-1 is expected to play an important role in advancing Oklo's isotope production capabilities and engineering models. The facility will conduct criticality and reactivity benchmarking activities to generate data that could improve reactor design and performance assessments.
These evaluations may also have applications beyond Oklo's own reactor projects. The company expects the resulting insights to potentially support both small and large light water reactors, including the broader existing light water reactor fleet. Better benchmarking data could help improve fuel performance and increase power output across these reactor systems.
The company highlighted the importance of taking Groves-1 from a greenfield site to criticality in less than a year. The company now intends to build on this achievement through continued reactor operations, testing and practical learning to develop the people and processes needed for its expanding project pipeline.
Groves-1 Experience to Inform Upcoming Isotope Projects
The operational experience accumulated at Groves-1 will also contribute to the development of Oklo's next major isotope initiative, Groves-2 Forge. Selected under the DOE's Nuclear Energy Launch Pad initiative, the planned pilot facility is designed to bring together different stages of the isotope production value chain.
Groves-2 Forge will combine reactor irradiation with hot-cell processing capabilities, covering activities such as isotope separation, product recovery, packaging and transportation. Its initial focus will be lutetium-177, an isotope used in targeted cancer treatments.
By advancing Groves-1 into unrestricted operations, Oklo is gaining an opportunity to test technologies, strengthen its technical workforce and gather operational insights that could support its future nuclear and isotope projects. The experience could prove valuable as the company moves toward developing an integrated isotope production platform and expanding its Aurora reactor ambitions.
OKLO’s Zacks Rank & Key Picks
Oklo is an advanced nuclear energy company focused on developing, owning and operating small nuclear power plants under its Aurora product line. Currently, OKLO has a Zacks Rank #3 (Hold).
Investors interested in the nuclear energy sector may consider some top-ranked stocks like Curtiss-Wright Corporation CW, GE Vernova Inc. GEV and NexGen Energy Ltd. NXE, each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
North Carolina-based Curtiss-Wright is a diversified multinational company that designs and overhauls precision components. The Zacks Consensus Estimate for CW’s 2026 earnings indicates 17.2% year-over-year growth.
GE Vernova is an energy company that includes Power, Wind and Electrification segments and is supported by its accelerator businesses of Advanced Research, Consulting Services and Financial Services. The Zacks Consensus Estimate for GEV’s 2026 earnings indicates 79.5% year-over-year growth.
NexGen Energy focuses on the acquisition, exploration and development of Canadian uranium projects. The Zacks Consensus Estimate for NXE’s 2026 earnings indicates 50% year-over-year growth.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Oklo Inc. (OKLO): Free Stock Analysis Report
Curtiss-Wright Corporation (CW): Free Stock Analysis Report
NexGen Energy (NXE): Free Stock Analysis Report
GE Vernova Inc. (GEV): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).